Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 7, 2007

Phenomenex to Distribute Beckman Coulter's IgY Proteome Enrichment Chemistry

  • Phenomenex inked a distribution agreement for Beckman Coulter's ProteomeLab™ IgY enrichment products for proteomics and biomarker discovery. The agreement grants Phenomenex exclusive distribution rights in the U.S., Canada, and countries in the EU. Based on avian-generated antibodies, ProteomeLab IgY-12 liquid chromatography and spin columns offer clean capture and a broad antigen-binding host range.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »